Medline Industries, LP vs Naseem A. Jaffrani, M.D.: FDA Enforcement Comparison

Medline Industries, LP has been the subject of 242 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Naseem A. Jaffrani, M.D..

Medline Industries, LP: 0 warning letters, 242 recalls, 0 approval records, 0 Form 483s.

Naseem A. Jaffrani, M.D.: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.

Side by side

Medline Industries, LP — Warning letters0

Naseem A. Jaffrani, M.D. — Warning letters1

Medline Industries, LP — Recalls242

Naseem A. Jaffrani, M.D. — Recalls0

Medline Industries, LP — Approval records0

Naseem A. Jaffrani, M.D. — Approval records0

Medline Industries, LP — Form 483s0

Naseem A. Jaffrani, M.D. — Form 483s0

Timeline

Medline Industries, LP

Most recent FDA action: July 1, 2026

Full history →

Naseem A. Jaffrani, M.D.

Most recent FDA action: May 4, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Medline Industries, LP vs Naseem A. Jaffrani, M.D.: FDA Enforcement Comparison." Argus HQ, accessed July 13, 2026. https://argushq.ai/compare/medline-industries-lp-vs-naseem-a-jaffrani-m-d

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗